Earnings season is coming fast for capital markets stocks, and Bank of America analyst Michael Carrier has re-positioned several of his stock ratings ahead of what he sees as a decent overall quarter. According to Carrier, trends in the third quarter were mixed and included rising markets and short-term interest rates, but also relatively low volume and a weaker dollar.
Big bank earnings season is once again right around the corner, with Morgan Stanley MS 0.12% and Goldman Sachs Group Inc GS 0.27% set to report on Oct. 17.
DexCom, Inc. DXCM 0.71% shares got hammered Sept. 28 when rival Abbott Laboratories ABT 1.17% received FDA approval for its FreeStyle Libre flash glucose monitoring system. Investors see Abbott’s new system as a lower-priced alternative to DexCom’s continuous glucose monitoring, and shares plummeted 36 percent following the news.
Last week, Leerink analyst David Larsen said that it’s only a matter of time before Amazon.com, Inc. AMZN 0.33% takes the plunge into the pharmacy business and that Amazon could be selling prescription drugs within two years’ time. On Monday, Bernstein analyst Lance Wilkes said Amazon investors may not need to wait two years.
Puerto Rico bonds took a huge hit last week when President Trump suggested the U.S. government may eliminate the nation’s debt in wake of its ongoing financial crisis.
The purpose of attending college is for students to get an education that will help them pursue a rewarding and enjoyable career. But high school and college students would be lying if they said making decent money isn’t also a major part of the equation.
Social media companies are battling it out tooth-and-nail for market share in the massive, high-growth industry. Facebook Inc FB 0.47%’s 121-percent gain and Twitter Inc TWTR 2.11%’s 66-percent loss highlight just how much is at stake for these companies and their investors.
After 20 years, Verizon Communications Inc. VZ 0.42% is officially shutting down AOL Instant Messenger. AIM was one of the first online messaging services to catch on in mainstream America. At its peak, AIM had more than 18 million simultaneous users, and the ability to communicate instantly made AIM a huge hit on Wall Street.
A new Financial Times article Friday reminded investors of an ongoing investigation in Massachusetts related to a practice known as brokerage payment for order flow. The article suggests broker order routing revenue may be at risk, sending shares of online brokerage stocks tumbling.
Pharmacy and health care investors should brace themselves — Amazon.com, Inc AMZN 0.33% is coming. In a pair of new research notes out this week, analysts at Leerink said it’s not a matter of if Amazon will make a move into the prescription drug business, it’s a matter of when and how.